top of page

PRESS RELEASE

Sep 16, 2024

VeganMed and Sater Pharmacy Team Up to Combat Alpha-gal Syndrome in Missouri

VeganMed is excited to announce its new partnership with Sater Pharmacy in Cassville, MO, to enhance support for Alpha-gal Syndrome patients. This collaboration aims to address the growing need for specialized, animal-free medication options in a state with one of the highest prevalence rates of the condition.

Sep 13, 2024

VeganMed’s Director of Medical Affairs and Operations Shares Insights on Hidden Animal Ingredients in Medicine with Vegconomist

Dr. Jasmine Uchi discusses the critical need for transparency around hidden animal ingredients in medications, advocating for consumer safety and informed choices.

Sep 11, 2024

VeganMed Partners with Love.Life Telehealth to Enhance Care for Alpha-gal Syndrome

VeganMed is thrilled to announce a new collaboration with Love.Life Telehealth. This partnership marks a significant step forward in addressing a critical issue identified through recent analysis: a widespread gap in knowledge among U.S. healthcare providers regarding Alpha-gal Syndrome (AGS).

Sep 3, 2024

Physician Awareness Key in Differentiating Chronic Spontaneous Urticaria and Alpha-gal Syndrome: New Insights from Leading Experts

An educational initiative aims to enhance physician awareness of the critical differences between Chronic Spontaneous Urticaria (CSU) and Alpha-gal Syndrome (AGS), two conditions with overlapping symptoms but distinct diagnostic and treatment approaches.

Aug 26, 2024

Vineyard Scripts and VeganMed Respond to Rising Alpha-gal Syndrome Cases on Martha's Vineyard

VeganMed is happy to partner with Vineyard Scripts to support alpha-gal patients.

Aug 23, 2024

VeganMed Collaborates with Ozark Total Healthcare Pharmacy to Tackle Alpha-gal Syndrome

VeganMed and Ozark Total Healthcare Pharmacy are partnering to enhance awareness and support for Alpha-gal Syndrome by providing specialized resources and tailored animal-free medication solutions.

Aug 19, 2024

VeganMed Partners with 501 Pharmacy to Address Alpha-gal Syndrome

VeganMed and 501 Pharmacy are partnering to enhance awareness and support for Alpha-gal Syndrome by providing specialized resources and tailored animal-free medication solutions.

Aug 13, 2024

VeganMed Partners with Johnny's Hometown Pharmacy to Support Alpha-gal Syndrome Care

VeganMed and Johnny's Hometown Pharmacy have partnered to improve care for Alpha-Gal Syndrome patients by offering tailored medication options in Roland, OK.

Aug 7, 2024

VeganMed Collaborates with Tahlequah Drug Company

VeganMed is thrilled to collaborate with Tahlequah Drug Company to improve access to animal-free medications and raise awareness about Alpha-gal Syndrome.

Aug 6, 2024

Groundbreaking TEDx Talk on Animal-Free Medications

VeganMed, Inc. is proud to share the highly anticipated TEDx Talk by Dr. Jasmine Uchi, focusing on the critical importance of animal-free medications for individuals with Alpha-gal Syndrome, vegans, vegetarians, and people with specific religious beliefs.

Jul 23, 2024

VeganMed Collaborates with Debbie’s Family Pharmacy

VeganMed is excited to partner with Debbie’s Family Pharmacy to enhance access to animal-free medications and boost awareness about Alpha-gal Syndrome.

Jul 17, 2024

VeganMed Collaborates with Claremore Indian Hospital Pharmacy

We are excited to share that VeganMed has entered a collaboration with Claremore Indian Hospital Pharmacy to enhance awareness of Alpha-gal Syndrome and highlight the importance of animal-free medications!

May 2, 2024

VeganMed CEO to Speak at First-Ever Congressional Briefing on Alpha-gal Syndrome

The U.S. Capitol will host its first-ever Congressional briefing dedicated to alpha-gal syndrome, a condition caused by tick bites that results in severe allergic reactions to mammalian meat, featuring a panel of esteemed experts and advocates.

Apr 8, 2024

New Study Unveils Medication Challenges for Alpha-gal Syndrome Patients at ACC 2024

A poster presentation at the American College of Cardiology (ACC) 73rd Annual Scientific Session & Expo highlights the challenges faced by individuals with Alpha-gal syndrome (AGS), revealing insights from social media discussions among AGS patients.

Mar 1, 2024

Call for Transparency in Medication Labeling: Addressing Animal-Derived Ingredients

New report underscores the urgent need for clear labeling and regulatory action on animal-derived ingredients in medications.

Nov 6, 2023

VeganMed and OptioRx Collaborate to Bring Patients Life Saving Medication

VeganMed, Inc. and OptioRx are excited to announce a groundbreaking collaboration to provide animal-free medications to patients across the United States.

Nov 1, 2023

VeganMed Partners with Leading Meal-Kit Delivery Services to Support Plant-Based Transitions for Alpha-Gal Syndrome Patients

In celebration of World Vegan Day, VeganMed proudly announces partnerships with five leading plant-based meal-kit delivery services.

Jul 14, 2023

Foley & Lardner LLP Files Petition for VeganMed, Inc. to Revamp FDA Labeling on Animal-Derived Ingredients

Foley has officially filed a citizen petition on behalf of VeganMed, calling on the FDA to update and clarify labeling regulations for animal-derived products.

Jun 27, 2023

Study Reveals Alarming Medication Challenges Faced by Alpha-Gal Syndrome Patients

A survey presented at the DIA's Global Annual Meeting in Boston (June 2023) highlights the severe challenges faced by Alpha-Gal Syndrome (AGS) patients due to alpha-gal sugar molecules found in mammalian products.

Jun 22, 2023

Pharmaceutical Industry Faces Challenges in Providing Accurate Information on Animal-Derived Ingredients

Amidst a growing consumer demand for transparency in medication ingredients, a new pilot project reveals critical gaps in the pharmaceutical industry's ability to provide accurate information on animal-derived ingredients.

bottom of page